KI
IRWD icon

Kula Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Kula Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$147K Buy
+14,003
New +$157K 0.04% 576

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Kula Investments's IRWD Position: Q1 2023 in Review

Kula Investments opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2023: 14,003 shares worth $147K. The stake represents 0.04% of the portfolio and ranks #576 among its holdings.

254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • Kula Investments held 14,003 shares of Ironwood Pharmaceuticals worth $147K as of Q1 2023.
  • Ironwood Pharmaceuticals was a new Kula Investments position in Q1 2023.
  • Ironwood Pharmaceuticals made up 0.04% of Kula Investments's portfolio in Q1 2023, its #576 holding.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.